Efficacy for combination therapy using double-balloon enteroscope and ultraslim endoscope for the treatment of hepatolithiasis in patients with hepaticojejunostomy

Efficacy for combination therapy using double-balloon enteroscope and ultraslim endoscope for the treatment of hepatolithiasis in patients with hepaticojejunostomy - Efficacy for endoscopic combination therapy for hepatolithiasis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024440

Enrollment

Registered

2016-11-01

Start date

2016-10-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatolithiasis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The patients with intrahepatic bile duct (IHBD) stones who underwent bowel reconstruction with hepaticojejunostomy(HJ) 2. Patients with informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with performance status 4 2.Patients with severe complications to other organs 3.Bowel reconstruction with Rouen-Y 4.Age<20 5.Patients without informed consent 6.MRI cannot be taken 7.Patients who are judged inappropriate by chief medical examiner

Design outcomes

Primary

Measure	Time frame
Detection rate of residual stone (After removal of hepatolithiasis using DBE, an ultraslim endoscope is directly inserted into the IHBD. The rate of detection of residual stones by ultraslim endoscope)	—

Secondary

Measure	Time frame
1. Success rate of direct cholangioscopy using ultraslim endoscope 2. Success rate of residual stone removal 3. Examination time 4. Adverse event 5. Rate of recurrence stone.	—

Countries

Japan

Contacts

Public ContactKazuyuki Matsumoto

Okayama University Hospital Department of Gastroenterology & Hepatology

matsumotokazuyuki0227@yahoo.co.jp086-235-7219

Outcome results